Neonatal morphine exposure alters E-NTPDase activity and gene expression pattern in spinal cord and cerebral cortex of rats

European Journal of Pharmacology

Volumn 642, Issue 1-3, 2010, Pages 72-76

  Rozisky, Joanna Ripoll ^a   da Silva, Rosane Souza ^b   Adachi, Lauren Spezia ^a   Capiotti, Katiucia Marques ^b   Ramos, Denise Barboza ^a   Bogo, Maurício Reis ^b   Bonan, Carla Denise ^b   Sarkis, João José Freitas ^a   Torres, Iraci Lucena da Silva ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

E NTPDase; Ecto 5'nucleotidase; Morphine; Neonatal rat; Nociception

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; DIMORF; ECTO 5' NUCLEOTIDASE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 1; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 2; ECTONUCLEOSIDE TRIPHOSPHATE DIPHOSPHOHYDROLASE 3; HYDROLASE; MORPHINE SULFATE; UNCLASSIFIED DRUG; ACID ANHYDRIDE HYDROLASE; MORPHINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; GENE EXPRESSION; HYDROLYSIS; MALE; NEUROMODULATION; NEUROTRANSMISSION; NEWBORN; NOCICEPTIVE STIMULATION; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SYNAPTOSOME; ANIMAL; CYTOLOGY; DRUG EFFECTS; ENZYMOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; TIME; WISTAR RAT;

ACID ANHYDRIDE HYDROLASES; ANIMALS; ANIMALS, NEWBORN; CEREBRAL CORTEX; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; MALE; MORPHINE; RATS; RATS, WISTAR; SPINAL CORD; SYNAPTOSOMES; TIME FACTORS;

EID: 77954624950     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.05.044     Document Type: Article

References (44)

1. Abbracchio M.P., Burnstock G., Verkhratsky A., Zimmermann H. Purinergic signalling in the nervous system: an overview. Trends Neurosci. 2009, 32:19-29.
2. Agteresch H.J., Dagnelie P.C., van den Berg J.W., Wilson J.H. Adenosine triphosphate: established and potential clinical applications. Drugs 1999, 58:211-232.
3. Anand K.J.S., Hall R.W. Morphine, hypotension, and intraventricular hemorrhage. Pediatrics 2006, 117:250-252.
4. Bailey A., Ledent C., Kelly M., Hourani S.M., Kitchen I. Changes in spinal delta and kappa opioid systems in mice deficient in the A2A receptor gene. J. Neurosci. 2002, 22:9210-9220.
5. Banjac A., Nedeljkovic N., Horvat A., Kanazir D., Nikezic G. Ontogenic profile of ecto-ATPase activity in rat hippocampal and caudate nucleus synaptic plasma membrane fractions. Physiol. Res. 2001, 50:411-418.
6. Battastini A.M.O., da Rocha J.B.T., Barcellos C.K., Dias R.D., Sarkis J.J.F. Characterization of an ATP diphosphohydrolase (EC 3.6.1.5) in synaptosomes from cerebral cortex of adult rats. Neurochem. Res. 1991, 16:1303-1310.
7. Beland B., Fitzgerald M. Mu- and delta opioid receptors are down-regulated in large primary sensory neurons during postnatal development in rats. Pain 2001, 90:143-150.
8. Bishop B. Neural plasticity: part 2. Postnatal maturation and function-induced plasticity. Phys. Ther. 1982, 62:1132-1143.
9. Bradford M.M.A. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding. Anal. Biochem. 1976, 72:218-251.
10. Burnstock G. Purine-mediated signalling in pain and visceral perception. Trends Pharmacol. Sci. 2001, 22:182-188.
11. Burnstock G. Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci. 2006, 27:166-176.
12. + 2- ATPase activity. Anal. Biochem. 1986, 157:375-380.
13. Chen W., Guidotti G. Soluble apyrases release ADP during ATP hydrolysis. Biochem. Biophys. Res. Commun. 2001, 282:90-95.
14. de Paula Cognato G., Bruno A.N., Vuaden F.C., Sarkis J.J., Bonan C.D. Ontogenetic profile of ectonucleotidase activities from brain synaptosomes of pilocarpine-treated rats. Int. J. Dev. Neurosci. 2005, 23:703-709.
15. Fiedler E.P., Marks M.J., Collins A.C. Postnatal development of cholinergic enzymes and receptors in mouse brain. J. Neurochem. 1987, 49:983-990.
16. Fink J.S., Weaver D.R., Rivkees S.A., Peterfreund R.A., Pollack A.E., Adler E.M., et al. Molecular cloning of the rat A2 adenosine receptor: selective co-expression with D2 dopamine receptors in rat striatum. Brain Res. Mol. Brain Res. 1992, 14:186-195.
17. Fitzgerald M., Anand K.J. Developmental neuroanatomy and neurophysiology of pain. Pain in Infants, Children, and Adolescents 1993, 11-31. Williams and Wilkins, Baltimore. N.L. Schechter, C.B. Berde, M. Yaster (Eds.).
18. Gerevich Z., Borvendeg S.J., Schröder W., Franke H., Wirkner K., Nörenberg W., Fürst S., Gillen C., Illes P. Inhibition of N-type voltage-activated calcium channels in rat dorsal root ganglion neurons by P2Y receptors is a possible mechanism of ADP-induced analgesia. J. Neurosci. 2004, 24:797-807.
19. Hack S.P., Christie M.J. Adaptations in adenosine signaling in drug dependence: therapeutic implications. Crit. Rev. Neurobiol. 2003, 15:235-274.
20. Heymann D., Reddington M., Kreutzberg G.W. Subcellular localization of 5'-nucleotidase in rat brain. J. Neurochem. 1984, 43:971-978.
21. Kaplan G.B., Coyle T.S. Adenosine kinase inhibitors attenuate opiate withdrawal via adenosine receptor activation. Eur. J. Pharmacol. 1998, 362:1-8.
22. Kaplan G.B., Sears M.T. Adenosine receptor agonists attenuate and adenosine receptor antagonists exacerbate opiate withdrawal signs. Psychopharmacology 1996, 123:64-70.
23. Kegel B., Braun N., Heine P., Maliszewski C.R., Zimmermann H. An ecto-ATP diphosphohydrolase are expressed in rat brain. Neuropharmacology 1997, 36:1189-1200.
24. Keil G.J., Delander G.E. Time-dependent antinociceptive interactions between opioids and nucleoside transport inhibitors. J. Pharmacol. Exp. Ther. 1995, 274:1387-1392.
25. Langer D., Hammer K., Koszalka P., Schrader J., Robson S., Zimmermann H. Distribution of ectonucleotidases in the rodent brain revisited. Cell Tissue Res. 2008, 334:199-217.
26. Nagy A.K., Houser C., Delgado-Escueta A.V. Rapid preparation of synaptosomes from mammalian brain using nontoxic isosmotic gradient (Percoll). J. Neurochem. 1984, 43:1114-1123.
27. Nedeljkovic N., Banjac A., Horvat A., Stojiljkovic M., Nikezic G. Developmental profile of NTPDase activity in synaptic plasma membranes isolated from rat cerebral cortex. Int. J. Dev. Neurosci. 2005, 23:45-51.
28. Nestler E.J. Molecular mechanisms of drug addiction. Neuropharmacology 2004, 47(Suppl. 1):24-32.
29. Oses J.P., Viola G.G., de Paula Cognato G., Júnior V.H., Hansel G., Böhmer A.E., Leke R., Bruno A.N., Bonan C.D., Bogo M.R., Portela L.V., Souza D.O., Sarkis J.J. Pentylenetetrazol kindling alters adenine and guanine nucleotide catabolism in rat hippocampal slices and cerebrospinal fluid. Epilepsy Res. 2007, 75:104-111.
30. Rabinowicz T., de Courten-Myers G.M., Petetot J.M., Xi G., de los Reyes E. Human cortex development: estimates of neuronal numbers indicate major loss late during gestation. J. Neuropathol. Exp. Neurol. 1996, 55:320-328.
31. Robson S.C., Sévigny J., Zimmermann H. The E-NTPDase family of ectonucleotidases: structure function relationships and pathophysiological significance. Purinergic Signal. 2006, 2:409-430.
32. Rozisky J.R., Dantas G., Adachi L.S., Alves V.S., Ferreira M.B., Sarkis J.J., Torres I.L. Long-term effect of morphine administration in young rats on the analgesic opioid response in adult life. Int. J. Dev. Neurosci. 2008, 26:561-565.
33. Ruan H.Z., Burnstock G. Localization of P2Y1 and P2Y4 receptors in dorsal root, nodose and trigeminal ganglia of the rat. Histochem. Cell Biol. 2003, 120:415-426.
34. Salem A., Hope W. Effect of adenosine receptor agonists and antagonists on the expression of opiate withdrawal in rats. Pharmacol. Biochem. Behav. 1997, 57:671-679.
35. Sawynok J., Liu X.J. Adenosine in the spinal cord and periphery: release and regulation of pain. Prog. Neurobiol. 2003, 69:313-340.
36. Schiffmann S.N., Vanderhaeghen J.J. Age-related loss of mRNA encoding adenosine A2 receptor in the rat striatum. Neurosci. Lett. 1993, 158:121-124.
37. Stanwood G.D., Levitt P. Drug exposure early in life: functional repercussions of changing neuropharmacology during sensitive periods of brain development. Curr. Opin. Pharmacol. 2004, 4:65-71.
38. Sweeney M.I., White T.D., Sawynok J. Involvement of adenosine in the spinal antinociceptive effects of morphine and noradrenaline. J. Pharmacol. Exp. Ther. 1987, 243:657-665.
39. Sweeney M.I., White T.D., Jhamandas K.H., Sawynok J. Morphine releases endogenous adenosine from the spinal cord in vivo. Eur. J. Pharmacol. 1987, 141:169-170.
40. Sweeney M.I., White T.D., Sawynok J. Intracerebroventricular morphine releases adenosine and adenosine 3', 5'-cyclic monophosphate from the spinal cord via a serotonergic mechanism. J. Pharmacol. Exp. Ther. 1991, 259:1013-1018.
41. Torres I.L., Battastini A.M., Buffon A., Fürstenau C.R., Siqueira I., Sarkis J.J., Dalmaz C., Ferreira M.B. Ecto-nucleotidase activities in spinal cord of rats changes as function of age. Int. J. Dev. Neurosci. 2003, 21:425-429.
42. Torres I.L.S., Bonan C.D., Crema L., Nunes M.L., Battastini A.M.B., Sarkis J.J.F., Dalmaz C., Ferreira M.B.C. Effect of drugs active at adenosine receptors upon chronic stress-induced hyperalgesia in rats. Eur. J. Pharmacol. 2003, 481:197-201.
43. Yao L., McFarland K., Fan P., Jiang Z., Ueda T., Diamond I. Adenosine A2a blockade prevents synergy between mu-opiate and cannabinoid CB1 receptors and eliminates heroin-seeking behavior in addicted rats. Proc. Natl. Acad. Sci. U. S. A. 2006, 103:7877-7882.
44. Zimmermann H. Nucleotide signaling in nervous system development. Pflugers Arch. 2006, 452:573-588.